- Home
- CIVB vs MXCT Comparison
CIVB vs MXCT Comparison
Compare CIVB & MXCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CIVB
- MXCT
- Stock Information
- Founded
- CIVB 1884
- MXCT 1999
- Country
- CIVB United States
- MXCT United States
- Employees
- CIVB N/A
- MXCT N/A
- Industry
- CIVB Major Banks
- MXCT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- CIVB Finance
- MXCT Health Care
- Exchange
- CIVB Nasdaq
- MXCT Nasdaq
- Market Cap
- CIVB 305.3M
- MXCT 361.8M
- IPO Year
- CIVB N/A
- MXCT 2021
- Fundamental
- Price
- CIVB $19.62
- MXCT $2.71
- Analyst Decision
- CIVB Buy
- MXCT Strong Buy
- Analyst Count
- CIVB 4
- MXCT 2
- Target Price
- CIVB $22.67
- MXCT $10.00
- AVG Volume (30 Days)
- CIVB 36.0K
- MXCT 701.5K
- Earning Date
- CIVB 04-29-2025
- MXCT 03-11-2025
- Dividend Yield
- CIVB 3.48%
- MXCT N/A
- EPS Growth
- CIVB N/A
- MXCT N/A
- EPS
- CIVB 2.01
- MXCT N/A
- Revenue
- CIVB $149,094,000.00
- MXCT $38,627,000.00
- Revenue This Year
- CIVB $15.51
- MXCT $20.01
- Revenue Next Year
- CIVB $5.58
- MXCT $26.64
- P/E Ratio
- CIVB $9.72
- MXCT N/A
- Revenue Growth
- CIVB N/A
- MXCT N/A
- 52 Week Low
- CIVB $13.60
- MXCT $2.62
- 52 Week High
- CIVB $23.70
- MXCT $5.26
- Technical
- Relative Strength Index (RSI)
- CIVB 45.87
- MXCT 27.30
- Support Level
- CIVB $19.35
- MXCT $2.62
- Resistance Level
- CIVB $20.01
- MXCT $3.17
- Average True Range (ATR)
- CIVB 0.52
- MXCT 0.17
- MACD
- CIVB 0.06
- MXCT -0.02
- Stochastic Oscillator
- CIVB 58.21
- MXCT 11.27
About CIVB Civista Bancshares Inc.
Civista Bancshares Inc is a financial holding company. Operating through its subsidiary, it engages in the business of community banking. Its business activity involves collecting customer deposits, making loans, purchasing securities, and offering trust services to its clients. The company's loan portfolio includes commercial and agriculture, commercial real estate-owner occupied, commercial real estate non-owner occupied, residential real estate, real estate construction, and consumer loans. Majority of its revenues are derived from the interest and fees gained on loans.
About MXCT MaxCyte Inc.
MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.